Pharmecutical giant, Biovail has lost the patent infringement case for its hit antidepressant drug Wellbutrin XL. The ruling will allow generic copies of the drug to enter the market. The U.S. court ruling caught the company unaware and resulted in in their stock's market value droppinga quarter....